Tandem Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.96M Sell
9,358
-2,571
-22% -$1.19M 0.33% 34
2026
Q1
$5.73M Sell
11,929
-2,244
-16% -$1.15M 0.28% 34
2025
Q4
$7.96M Sell
14,173
-535
-4% -$304K 0.3% 30
2025
Q3
$7.56M Sell
14,708
-178
-1% -$77.7K 0.26% 32
2025
Q2
$4.67M Buy
14,886
+3,198
+27% +$960K 0.16% 38
2025
Q1
$3.56M Buy
+11,688
New +$3.93M 0.12% 40

Other funds holding MEDP

Tandem Investment Advisors's MEDP Position: Q2 2026 in Review

Tandem Investment Advisors reduced its Medpace (MEDP) stake by 22% in Q2 2026, selling an estimated $1.19M and leaving 9,358 shares worth $4.96M. The position accounts for 0.33% of the portfolio, ranked #34.

Tandem Investment Advisors first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.96M in Q4 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Tandem Investment Advisors held 9,358 shares of Medpace worth $4.96M as of Q2 2026.
  • Tandem Investment Advisors sold 2,571 Medpace shares in Q2 2026, an estimated $1.19M.
  • Medpace made up 0.33% of Tandem Investment Advisors's portfolio in Q2 2026, its #34 holding.
  • Tandem Investment Advisors first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Tandem Investment Advisors's Medpace position peaked at $7.96M in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Tandem Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.